Wealth Effects LLC Acquires Shares of 248,021 Enovix Corporation $ENVX

Posted by Geri Gentry on Aug 17th, 2026

Wealth Effects LLC bought a new position in shares of Enovix Corporation (NASDAQ:ENVX – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 248,021 shares of the company’s stock, valued at approximately $1,505,000.

A number of other large investors have also modified their holdings of ENVX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Enovix by 5.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company’s stock valued at $722,000 after buying an additional 4,780 shares during the last quarter. NewEdge Advisors LLC lifted its stake in shares of Enovix by 10.4% in the first quarter. NewEdge Advisors LLC now owns 26,257 shares of the company’s stock worth $193,000 after buying an additional 2,481 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Enovix by 65.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock worth $8,351,000 after acquiring an additional 449,934 shares during the last quarter. Caxton Associates LLP acquired a new position in Enovix during the first quarter worth about $190,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Enovix by 18.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company’s stock valued at $2,628,000 after acquiring an additional 55,676 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Stock Performance

Enovix stock opened at $4.39 on Monday. The firm has a 50 day simple moving average of $5.33 and a 200-day simple moving average of $5.86. Enovix Corporation has a 1-year low of $3.67 and a 1-year high of $14.21. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The stock has a market cap of $957.68 million, a price-to-earnings ratio of -5.42 and a beta of 2.32.

Enovix (NASDAQ:ENVX – Get Free Report) last announced its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. The business had revenue of $9.02 million during the quarter, compared to the consensus estimate of $8.43 million. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The business’s revenue was up 20.8% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.13) EPS. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. On average, analysts expect that Enovix Corporation will post -0.78 EPS for the current year.

Analyst Ratings Changes

A number of analysts have commented on the stock. JPMorgan Chase & Co. downgraded shares of Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. TD Cowen lowered their target price on Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a report on Friday, July 24th. Cantor Fitzgerald restated an “overweight” rating and issued a $25.00 price target on shares of Enovix in a research report on Thursday. B. Riley Financial cut their price target on Enovix from $10.00 to $9.00 and set a “buy” rating for the company in a report on Thursday. Finally, Benchmark lowered their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Six analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Enovix presently has a consensus rating of “Hold” and an average price target of $11.86.

Read Our Latest Stock Analysis on ENVX

Enovix Profile

(Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

Wealth Effects LLC Acquires Shares of 248,021 Enovix Corporation $ENVX

Enovix Stock Performance

Analyst Ratings Changes

Enovix Profile

See Also

You might be interested in: